Head And Neck Cancer Stories
- Used in combination with chemo, the immunotherapy drug Nivolumab has had promising results in treating tumors in advanced head and neck cancer patients.
- As of Jan. 1, 2016, more than 15.5 million Americans have a history of cancer; in 2026, this number will reach more than 20 million.
- Bristol-Myers Squibb's cancer immunotherapy drug, Opdivo, helped advanced head and neck cancer patients with a dismal prognosis live longer than other standard treatments, according to data from a late-stage study presented on Tuesday.
- President Obama promised to undertake a national effort to cure cancer, a “new moonshot” with Vice President Biden in charge of “mission control.”
- A compound found in broccoli may serve as natural treatment for cancer prevention.
- A new study has identified four proteins that play a crucial role in drug-resistant HPV-negative head-and-neck squamous cell cancers, bringing hope to researchers seeking better drug targets.
- The anticonvulsant and mood-stabilizing drug valproic acid is associated with a 34 percent lower risk of head and neck cancer, a new study finds.
- Adults who continuously suffer from cavities may reduce their risk of head and neck cancer.